Metraipolis › archive › dc_ddff6bfb3bbf
Brain radiotherapy added to first-line immunochemotherapy improves survival in patients with treatment-naïve, driver-negative lung adenocarcinoma and… — Europe PMC PMID:41971455
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41971455
- DOI
- 10.3389/fonc.2026.1808429
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T20:53:14.101Z
- SHA-256 of the archived text
ceac0498b2ab2c7a039104fc9ab63c41c272ac4fa63a6ae0964f53100c6eac28- Stable URL of this page
https://metraipolis.com/documento/dc_ddff6bfb3bbf
How to cite
Brain radiotherapy added to first-line immunochemotherapy improves survival in patients with treatment-naïve, driver-negative lung adenocarcinoma and… — Europe PMC PMID:41971455 — Europe PMC (en), https://europepmc.org/article/MED/41971455 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ddff6bfb3bbf (Metraipolis archive dc_ddff6bfb3bbf, sha256 ceac0498b2ab2c7a039104fc9ab63c41c272ac4fa63a6ae0964f53100c6eac28)
BibTeX
@misc{dcddff6bfb3bbf,
title = {Brain radiotherapy added to first-line immunochemotherapy improves survival in patients with treatment-naïve, driver-negative lung adenocarcinoma and… — Europe PMC PMID:41971455},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41971455},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ddff6bfb3bbf; sha256 ceac0498b2ab2c7a039104fc9ab63c41c272ac4fa63a6ae0964f53100c6eac28},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41971455. Agents can read the archived copy with the MCP tool read_document.